Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 1 49-1, 2001, Pages

  Leon Velarde F ^a,b,c   Bourin, M C ^d   Germack, R ^a   Mohammadi, K ^c   Crozatier, B ^c   Richalet, J P ^a,c  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c Médicale Unité 400   (France)

^d Unité 99   (France)

Author keywords

Adenylate cyclase; Adrenergic receptors; G proteins; Protein kinase C; Ventricular hypertrophy

Indexed keywords

ADENYLATE CYCLASE; ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR; CHOLERA TOXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HEART RECEPTOR; ISOPRENALINE; NORADRENALIN; PERTUSSIS TOXIN; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HYPOXIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

EID: 0342526191     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.1.r274     Document Type: Article

References (36)

1. Baker SP, Boyd HM, and Potter LT. Effect of propanolol on β-adrenoceptors in rats hearts. Br J Pharmacol 68: 8-10, 1980.
2. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 246-254, 1976.
3. Brown L, Sernia C, Newling R, and Fletcher P. Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats. J Cardiovasc Pharmacol 20: 316-323, 1992.
4. Chang HY, Klein RM, and Kunos G. Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats. J Pharmacol Exp Ther 221: 784-789, 1982.
5. Deighton NM, Brown AD, Hamilton CA, and Reid JL. Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit. Arch Pharm (Weinheim) 338: 517-522, 1988.
6. Deng X-F, Sculptoreanu A, Mulay S, Peri KG, Li JF, Zheng WH, Chemtob S, and Varma DR. Crosstalk between alpha-1A and alpha-1B adrenoceptors in neonatal rat myocradium: implications in cardiac hypertrophy. J Pharmacol Exp Ther 286: 489-496, 1998.
7. Dong E, Yatani A, Mohan A, and Liang CS. Myocardial beta-adrenoceptor down-regulation by norepinephrine is linked to reduced norepinephrine activity. Eur J Pharmacol 384: 17-24, 1999.
8. 1-adrenergic stimulation in hypoxic cardiac myocytes. J Clin Invest 83: 1409-1413, 1989.
9. Hislop A and Reid L. New findings in pulmonary arteries of rats with hypoxia induced pulmonary hypertension. Br J Exp Pathol 57: 542-554, 1976.
10. Johnson RC, Alvarez R, and Salomon Y. Determination of adenylyl cyclase catalytic activity using single and double column procedures. Methods Enzymol 238: 31-55, 1994.
11. Kacimi R, Moalic JM, Aldashev A, Vatner D, Richalet J-P, and Crozatier B. Differential regulation of G protein expression in rat hearts exposed to chronic hypoxia. Am J Physiol Heart Circ Physiol 269: H1865-H1873, 1995.
12. Kacimi R, Richalet J-P, Corsin A, Abousahl E, and Crozatier B. Hypoxia-induced downregulation of β-adrenergic receptors in heart rat. J Appl Physiol 73: 1377-1382, 1992.
13. 1-Adrenoceptor mediated signal transduction in neonatal rat ventricular myocytes: effects of prolonged hypoxia and reoxygenation. Cardiovasc Res 25: 609-616, 1991.
14. Karliner JS, Simpson PC, Honbo N, and Woloszyn W. Mechanism and time course of beta 1-adrenoceptor desensitization in mammalian cardiac myocytes. Cardiovasc Res 20: 221-228, 1986.
15. Karliner JS and Simpson PC. β-Adrenoceptor and adenylate cyclase regulation in cardiac myocyte growth. Basic Res Cardiol 83: 655-663, 1988.
16. Kudej RK, Iwase M, Uechi M, Vatner DE, Oka N, Ishikawa Y, Shannon RP, Bishop SP, and Vatner SF. Effects of β-adrenergic receptor stimulation in mice. J Mol Cell Cardiol 29: 2735-2746, 1997.
17. Laycock SK, McMurray J, Kane KA, and Parrat JR. Effect of chronic norepinephrine administration on cardiac function in rats. J Cardiovasc Pharmacol 26: 584-589, 1995.
18. León-Velarde F, Richalet J-P, Chavez J-C, Kacimi R, Rivera-Chira M, Palacios JA, and Clark D. Hypoxia and normoxia-induced reversibility of autonomie control in Andean guinea pig heart. J Appl Physiol 81: 2229-2234, 1996.
19. 1-adrenergic receptor-stimulated cardiac hypertrophy and signaling. Circulation 92: 918-925, 1995.
20. Maher JT, Denniston SC, Wolfe DL, and Cymerman A. Mechanism of the attenuated cardiac response to β-adrenergic stimulation in chronic hypoxia. J Appl Physiol 44: 647-657, 1978.
21. Maher JT, Manchanda SC, Cymerman A, Wolfe DL, and Hartley H. Cardiovascular responsiveness to β-adrenergic stimulation and blockade in chronic hypoxia. Am J Physiol 228: 477-481, 1975.
22. Mardon K, Merlet P, Syrota A, and Mazière B. Effects of 5-day hypoxia on cardiac adrenergic neurotransmission in rats. J Appl Physiol 85: 890-897, 1998.
23. Mazzeo RS, Wolfel EE, Butterfield GE, and Reeves JT. Sympathetic responses during 21 days at high altitude (4,300 m) as determined by urinary and arterial catecholamines. Metabolism 43: 1226-1232, 1994.
24. Munson PJ and Rodbard D. Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 107: 220-239, 1980.
25. Neuman J, Schmitz W, Scholz H, Von Meyerinck L, Doring V, and Kalmar P. Increase in myocardial Gi-proteins in heart failure. Lancet 2: 936-938, 1988.
26. Patel MB, Stewart JM, Loud AV, Anversa P, Wang J, Fiegel L, and Hintze TH. Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine. Circulation 84: 2091-2100, 1991.
27. Premont RT, Matsuoka I, Mattei MG, Pouille Y, Deger N, and Hanoune J. Identification and characterization of a widely expressed form of adenylyl cyclase. J Biol Chem 271: 13900-13907, 1996.
28. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, and Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol Heart Circ Physiol 236: H818-H827, 1979.
29. Reithmann C, Gierschik P, Sidiropoulos D, Werdan K, and Jakobs KH. Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits. Eur J Pharmacol 172: 211-221, 1989.
30. Richalet J-P. The heart and adrenergic system in hypoxia. In: Hypoxia: The Adaptations, edited by Sutton JR, Coates G, and Remmers JE. Philadelphia, PA: BC Decker, 1990, p. 231-240.
31. Rocha-Singh K, Honbo NY, and Karliner JS. Hypoxia and glucose independently regulate the β-adrenergic receptor-adenylate cyclase system in cardiac myocytes. J Clin Invest 88: 204-213, 1991.
32. Rostrup M. Catecholamines, hypoxia and high altitude. Acta Physiol Scand 162: 389-399, 1998.
33. Sethi R, Elimban V, Chapman D, Dixon IMC, and Dhalla NS. Differential alterations in left and right ventricle G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol 30: 2153-2163, 1998.
34. Voelkel NF, Hegstrand L, Reeves JT, McMurty IF, and Molinoff PB. Effects of hypoxia on density of β-adrenergic receptors. J Appl Physiol Respir Environ Exercise Physiol 50: 363-366, 1981.
35. Xiao RP, Cheng H, Zhou Y-Y, Kuschel M, and Lakatta EG. Recent advances in cardiac β2-adrenergic signal transduction. Circ Res 85: 1092-1100, 1999.
36. Yamori Y, Tarazi RC, and Ooshima A. Effect of β-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats. Clin Sci (Colch) 59: 457-460, 1980.